1. Home
  2. LNN vs KURA Comparison

LNN vs KURA Comparison

Compare LNN & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lindsay Corporation

LNN

Lindsay Corporation

HOLD

Current Price

$114.42

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Kura Oncology Inc.

KURA

Kura Oncology Inc.

HOLD

Current Price

$12.89

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LNN
KURA
Founded
1954
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
LNN
KURA
Price
$114.42
$12.89
Analyst Decision
Hold
Buy
Analyst Count
1
11
Target Price
$113.00
$25.56
AVG Volume (30 Days)
97.7K
2.1M
Earning Date
04-02-2026
05-12-2026
Dividend Yield
1.35%
N/A
EPS Growth
12.81
N/A
EPS
4.22
N/A
Revenue
$676,368,000.00
$67,482,000.00
Revenue This Year
N/A
$28.28
Revenue Next Year
$4.74
$106.37
P/E Ratio
$27.21
N/A
Revenue Growth
11.41
25.24
52 Week Low
$97.27
$7.36
52 Week High
$148.00
$13.90

Technical Indicators

Market Signals
Indicator
LNN
KURA
Relative Strength Index (RSI) 48.26 63.58
Support Level $111.23 $8.07
Resistance Level $114.63 $13.90
Average True Range (ATR) 2.96 0.76
MACD -0.03 0.14
Stochastic Oscillator 36.95 74.37

Price Performance

Historical Comparison
LNN
KURA

About LNN Lindsay Corporation

Lindsay Corp provides proprietary water management and road infrastructure products and services. It manufactures and distributes agricultural irrigation equipment through two segments: Irrigation and Infrastructure. The Irrigation segment makes center pivot, lateral move, and hose reel irrigation systems and parts. The Infrastructure segment produces barriers, crash cushions, road marking and safety equipment, and railroad signals. The majority of revenue is from the Irrigation segment. The company operates in the United States and international markets, with the majority of revenue coming from the United States.

About KURA Kura Oncology Inc.

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

Share on Social Networks: